| 22427-39-0 |
| Sanchinoside C1 |
| Panaxoside A |
| Ginsenoside A2 |
| Panaxoside Rg1 |
| Sanchinoside Rg1 |
| (3beta,6alpha,12beta)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-beta-D-Glucopyranoside |
| CHEBI:67987 |
| DTXSID70945111 |
| PJ788634QY |
| (6)-beta-D-Glucopyranosyl-(20)-beta-D-glucopyranosyl-20S-protopanaxatriol |
| (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
| (3beta,6alpha,12beta)-3,12-Dihydroxydammar-24-ene-6,20-diylbis(beta-D-glucopyranoside) |
| beta-D-Glucopyranoside, (3beta,6alpha,12beta)-3,12-dihydroxy dammar-24-ene-6,20-diylbis- |
| beta-D-Glucopyranoside, (3beta,6alpha,12beta)-3,12-dihydroxydammar-24-ene-6,20-diyl bis- |
| (2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-((2S)-6-methyl-2-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxyhept-5-en-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-6-yl)oxy)-6-(hydroxymethyl)oxane-3,4,5-triol |
| RefChem:37717 |
| DTXCID701373437 |
| 244-989-9 |
| ginsenoside-Rg(1) |
| sanchinoside C(1) |
| MFCD00210293 |
| (20S)-ginsenoside Rg1 |
| ginsenoside-Rg1 |
| Ginsenoside g1 |
| AC1L9BXQ |
| Panaxoside A;Panaxoside Rg1 |
| CHEMBL501637 |
| UNII-PJ788634QY |
| GinsenosideRG1 |
| YURJSTAIMNSZAE-HHNZYBFYSA-N |
| Ginsenoside Rg1? |
| RG1 |
| EINECS 244-989-9 |
| BIDD:ER0075 |
| orb1305031 |
| SCHEMBL19875635 |
| GINSENOSIDE RG1 [USP-RS] |
| GINSENOSIDE RG1 [WHO-DD] |
| HMS3885M12 |
| (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1,5-dimethyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hex-4-enyl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol |
| EX-A6784 |
| HY-N0045 |
| MSK40042 |
| Ginsenoside Rg1, analytical standard |
| s3923 |
| AKOS037514672 |
| CCG-270492 |
| CS-3832 |
| DB06750 |
| OG09289 |
| NCGC00483065-01 |
| BS-16671 |
| SY068756 |
| Ginsenoside Rg1 (saponin of Panax ginseng) |
| G0533 |
| NS00073634 |
| C08946 |
| 427G390 |
| Q2276594 |
| Ginsenoside Rg1, primary pharmaceutical reference standard |
| Ginsenoside Rg1, United States Pharmacopeia (USP) Reference Standard |
| (3|A,6|A,12|A)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-|A-D-glucopyranoside |
| (6)-.BETA.-D-GLUCOPYRANOSYL-(20)-.BETA.-D-GLUCOPYRANOSYL-20S- PROTOPANAXATRIOL |
| (3.BETA.,6.ALPHA.,12.BETA.)-3,12-DIHYDROXYDAMMAR-24-ENE-6,20- DIYLBIS(.BETA.-D-GLUCOPYRANOSIDE) |
| (3?,6?,12?)-3,12-Dihydroxydammar-24-ene-6,20-diylbis-?-D-glucopyranoside;Panaxoside A;Ginsenoside A2;Sanchinoside C1 |
| (3beta,alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl beta-D-glucopyranoside |
| .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,6.ALPHA.,12.BETA.)-3,12- DIHYDROXY DAMMAR-24-ENE-6,20-DIYLBIS- |
| .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,6.ALPHA.,12.BETA.)-3,12-DIHYDROXYDAMMAR-24-ENE-6,20-DIYL BIS- |
| GINSENOSIDE RG1 (CONSTITUENT OF AMERICAN GINSENG, ASIAN GINSENG, AND TIENCHI GINSENG) [DSC] |
|
There are more than 10 synonyms. If you wish to see them all click here.
|